Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
15.46
-0.65 (-4.07%)
At close: May 5, 2026, 4:00 PM EDT
15.48
+0.03 (0.16%)
After-hours: May 5, 2026, 7:54 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $137.33 million as of May 5, 2026. Its market cap has increased by 721.64% in one year.
Market Cap
137.33M
Enterprise Value
125.28M
1-Year Change
721.64%
Ranking
Category
Stock Price
$15.46
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $137.33M, an increase of 269.97%. That is a compound annual growth rate of 20.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 137.33M | 1,060.46% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agenus | 154.36M |
| InflaRx | 153.98M |
| Alps Group | 152.92M |
| Galectin Therapeutics | 150.74M |
| Kazia Therapeutics | 146.72M |
| Spero Therapeutics | 144.73M |
| Immunic | 144.43M |
| Connect Biopharma Holdings | 140.17M |